ACC 2021 | Emergent CABG for acute MI: Benefits Despite Risk

The latest figures show a lower number of emergency CABG for acute MI, and in turn increased primary PCI. 

ACC 2021 | Cirugía de emergencia en el infarto: beneficios a pesar del alto riesgo

The combination of surgeons not willing to take risks and interventional cardiologists empowered to treat practically any lesion has resulted in fewer patients receiving emergency CABG. Only a few years ago, interventional cardiologists at least had the “courtesy” to agree on a treatment strategy with the surgeon on call. Several years of choosing PCI over CABG have granted interventionists clearance to bypass surgeons and directly proceed to percutaneous intervention, practically in every center. 

This study presented today at ACC 2021 simultaneously published in JAHA, shows the figures behind the above statements. Comparing the years 2000 and 2017, emergency CABG saw a 90% reduction. 

It is also clear that surgical techniques and post operatory care have improved in the same period. This has contributed to keep a clear benefit in terms of mortality, despite volume reduction and case selection. 

When comparing patients undergoing surgery in the first part of the study vs the second part, some interesting information becomes clear


Read also: ACC 2021 | LAAOS III: Appendage Closure During Central Vascular Surgery.


Patients treated in the second, most recent period, were more frequently non-STEMI cases (80.5% vs 56.1%), more often presented non-cardiac multiorgan failure (26.1% vs 8.4%), presented cardiogenic shock (11.5% vs 6.4%) and received mechanical circulatory support (19.8% vs 18.7%; p< 0.001 for all comparisons). 

Despite all the above mentioned, mortality in these periods resulted similar (5.3% in 2000 vs 3.6% in 2017).

Original Title: Temporal trends, clinical characteristics and outcomes of emergent coronary artery bypass grafting for acute myocardial infarction in the United States.

Reference: Patlolla SH et al. Presentado en el congreso de la ACC 2021 y publicado simultáneamente en J Am Heart Assoc.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...